You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

CLINICAL TRIALS PROFILE FOR CORTROSYN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Cortrosyn

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00462644 ↗ Evaluation of Etomidate on Adrenal Function in Trauma Patients Completed University of Tennessee N/A 2006-02-01 Trauma patients are at increased risk for adrenal function insufficiency. A commonly used agent for rapid sequence intubation (RSI) is known to decrease adrenal function. We want to determine the incidence of adrenocortical insufficiency and its significance during the first 24 hours of resuscitation following RSI in trauma patients.
NCT00484679 ↗ Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata Completed National Alopecia Areata Foundation Phase 2 2007-05-01 The purpose of the study is to see whether treating alopecia areata with injections of the corticosteroid, Triamcinolone acetonide 10mg/cc (Kenalog-10), has an impact on the adrenal glands.
NCT00484679 ↗ Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata Completed University of Minnesota Phase 2 2007-05-01 The purpose of the study is to see whether treating alopecia areata with injections of the corticosteroid, Triamcinolone acetonide 10mg/cc (Kenalog-10), has an impact on the adrenal glands.
NCT00484679 ↗ Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata Completed University of Minnesota - Clinical and Translational Science Institute Phase 2 2007-05-01 The purpose of the study is to see whether treating alopecia areata with injections of the corticosteroid, Triamcinolone acetonide 10mg/cc (Kenalog-10), has an impact on the adrenal glands.
NCT00817219 ↗ Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris Completed LEO Pharma Phase 2 2009-07-01 The purpose of this study is to evaluate the safety and efficacy of 4 weeks of TACLONEX ointment in adolescent patients with psoriasis vulgaris.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cortrosyn

Condition Name

Condition Name for Cortrosyn
Intervention Trials
Sepsis 1
Stress 1
Adrenal Insufficiency 1
Alopecia Areata 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Cortrosyn
Intervention Trials
Sepsis 1
Alopecia Areata 1
Night Blindness 1
Alopecia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Cortrosyn

Trials by Country

Trials by Country for Cortrosyn
Location Trials
United States 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Cortrosyn
Location Trials
Virginia 2
Tennessee 2
Michigan 1
Washington 1
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Cortrosyn

Clinical Trial Phase

Clinical Trial Phase for Cortrosyn
Clinical Trial Phase Trials
Phase 4 1
Phase 2 2
Phase 1 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Cortrosyn
Clinical Trial Phase Trials
Completed 5
Active, not recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cortrosyn

Sponsor Name

Sponsor Name for Cortrosyn
Sponsor Trials
University of Virginia 1
University of Michigan 1
National Heart, Lung, and Blood Institute (NHLBI) 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Cortrosyn
Sponsor Trials
Other 10
NIH 3
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.